Health Trials

Salivary Gland Carcinoma

2

Review clinical trials related to Salivary Gland Carcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing

Patients with salivary gland carcinoma were divided into groups according to HER2, NTRK, AR, TROP-2, etc. Patients in different groups were given precision targeted therapy or chemotherapy to evaluate the efficacy (ORR rate) and safety of precision therapy.

Participants needed: 39
Trial details
Phase: Phase 2Age: 18-100Biological sex: AllType: InterventionalSponsor: Peking Union Medical CollegeUpdated: Apr 2, 2026Locations: 2
Eligibility criteria

Patients with histopathologic diagnosis of salivary gland carcinoma [+4]

Known hypersensitivity or delayed anaphylaxis to any agents in this trial; [+7]

Read more
Status: Recruiting

Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma

A Phase II, multi-center, single-arm, non-blinded study combining androgen deprivation therapy (ADT) and pembrolizumab for patients with metastatic or locally recurrent androgen receptor-positive salivary gland carcinoma, not amenable to surgery or radiation.

Participants needed: 20
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Manish PatelUpdated: Dec 31, 2025Locations: 7
Eligibility criteria

Written informed consent and HIPAA authorization for release of personal health... [+19]

Women of childbearing age with a positive serum pregnancy test within 72 hours p... [+18]

Read more